Genmab shares jump 13% on colorectal cancer drug trial results
Genmab shares jump 13% on colorectal cancer drug trial results Yahoo Finance
Онкология
Колоректальный рак
210 материалов по теме, собраны автоматически из проверенных источников
Онкология
Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer BioSpace
Онкология
Новости медицины от 25 октября: заболеваемость колоректальным раком растет, и многие люди упускают возможности лечения из-за поздней диагностики.
Новости медицины от 25 октября: заболеваемость колоректальным раком растет, и многие люди упускают возможности лечения из-за поздней диагностики. Vietnam.vn
Онкология
Agenus reports response rate in colon cancer trial (AGEN:NASDAQ)
Agenus reports response rate in colon cancer trial (AGEN:NASDAQ) Seeking Alpha
Онкология
Genmab, Incyte team up to develop experimental colorectal cancer treatment (INCY:NASDAQ)
Genmab, Incyte team up to develop experimental colorectal cancer treatment (INCY:NASDAQ) Seeking Alpha
Онкология
EMT2 at ESMO 2026: Eicosapentaenoic Acid After Colorectal Cancer Liver Metastasis Resection
EMT2 at ESMO 2026: Eicosapentaenoic Acid After Colorectal Cancer Liver Metastasis Resection Oncodaily
Онкология
IROCAS at ESMO 2026: mFOLFIRINOX vs mFOLFOX6 in High-Risk Stage III Colon Cancer
IROCAS at ESMO 2026: mFOLFIRINOX vs mFOLFOX6 in High-Risk Stage III Colon Cancer Oncodaily
Онкология
Michael Sapienza: FDA Approves First Adjuvant Immunotherapy Regimen for Stage III dMMR Colorectal Cancer
Michael Sapienza: FDA Approves First Adjuvant Immunotherapy Regimen for Stage III dMMR Colorectal Cancer Oncodaily
Онкология
AI map of bowel tumours reveals drug vulnerabilities in hardest-to-treat colorectal cancer
AI map of bowel tumours reveals drug vulnerabilities in hardest-to-treat colorectal cancer Bioengineer.org
Онкология
Temab-A + Bevacizumab at ESMO 2026: Long-Term Phase I Results in Previously Treated Colorectal Cancer
Temab-A + Bevacizumab at ESMO 2026: Long-Term Phase I Results in Previously Treated Colorectal Cancer Oncodaily
Онкология
Incyte (INCY) Starts KRAS G12D Colorectal Cancer Trial Collaboration
Incyte (INCY) Starts KRAS G12D Colorectal Cancer Trial Collaboration Yahoo Finance
Онкология
Study identifies potential new treatment targets for the most common type of bowel cancer
Research published today identifies potential new ways to treat the most common type of colorectal cancer in Ireland. The study, conducted by an international research team led by RCSI University of Medicine and Health Sciences and The Institute of Cancer Research, London, provides a roadmap for repurposing existing…
🎗️
Онкология
Выявлены уязвимости MSS-колоректального рака — News-Medical
Выявлены уязвимости MSS-колоректального рака — News-Medical UA.NEWS
Онкология
Study identifies potential new ways to treat the most common type of bowel cancer - News-Medical
Study identifies potential new ways to treat the most common type of bowel cancer News-Medical
Онкология
No disease recurrences after short course of neoadjuvant immunotherapy, according to follow-up
A short course of neoadjuvant immunotherapy continues to show long-term outcomes in patients with locally advanced mismatch repair–deficient (dMMR) colon cancer. In the NICHE-2 study, none of the 111 patients in the primary efficacy population experienced disease recurrence, and all were alive at their most recent…